UNSPSC 51101928: Cycloguanil

This classification denotes an antimalarial and folic acid antagonist with the molecular formula C11H14ClN5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 26RM326WVN, chemically known as 1-(4-chlorophenyl)-1,6-dihydro-6,6-dimethyl-1,3,5-triazine-2,4-diamine but generally known as cycloguanil, which bears US NIH Compound Identifier 9049. European Medicines Agency schedules Cycloguanil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01526MIG.

World Health Organization schedules cycloguanil in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, CYCLOGUANIL remains the US FDA Preferred Term for this commodity. Cycloguanil bears US NLM identifiers UMLS ID C0056751 and NCI Concept Code C81015. SMILES: CC1(N=C(N=C(N1C2=CC=C(C=C2)Cl)N)N)C.

UNSPSC 51101928 Cycloguanil is a Commodity code that does not align with the work actually being solicited under it in recent state and local procurement activity. The recent opportunities tagged to this code involve naloxone procurement, direct-to-manufacturer pharmacy programs, medical and first aid supplies for emergency responders, and generic multi-source pharmaceuticals and OTC products—none of which concern cycloguanil, an antimalarial compound with limited domestic public-health procurement use. The mismatch suggests either miscoding in the source data or a fundamental disconnect between the taxonomy assignment and current buying practice.

No relevant recent opportunities for cycloguanil procurement appear in the state and local market. The code shows little to no active buying signal among state agencies, county governments, cities, school districts, transit authorities, or special-purpose districts during the review period.